AKHNATON
52 awards on record, from 1 public buyer. Values run $5,278 to $100,608.
This supplier holds a profile in the directory: AKHNATON.
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$96,400
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$89,045
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$96,400
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$94,036
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$96,663
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$91,934
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods May 17, 2020$91,807
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,608
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,608
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,608
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,159
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,127
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$100,127
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$99,984
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Feb 12, 2020$99,984
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Dec 29, 2019$98,831
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Dec 29, 2019$98,831
the currently used drugs through the Egyptian national treatment program are combination of Sofosbuvir 400mg+ Daclatasvir 60 mg for 12...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Dec 29, 2019$98,831
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$97,692
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$97,813
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$98,341
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$98,325
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$98,704
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$5,278
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the...
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Nov 13, 2019$98,440